You just read:

Novoteris, LLC., Medical Device and Pharmaceutical Product Innovators, Receives Orphan Drug Designation for Nitric Oxide for the Treatment of Cystic Fibrosis

News provided by

Novoteris, LLC.

Oct 09, 2013, 08:45 ET